Romania - Romanian - ANMDM (Agentia Nationala a Medicamentului si a Dispozitivelor Medicale)

mcneil ab - suedia - nicotinum - guma medicamentoasa mast. - 2mg - med. pentru tratamentul dependentei de substante med. utilizate in tratamentul dependentei de nicotina

Romania - Romanian - ANMDM (Agentia Nationala a Medicamentului si a Dispozitivelor Medicale)

mcneil ab - suedia - nicotinum - guma medicamentoasa mast. - 4mg - med. pentru tratamentul dependentei de substante med. utilizate in tratamentul dependentei de nicotina

European Union - Romanian - EMA (European Medicines Agency)

astrazeneca ab - acalabrutinib - leucemie, limfocitică, cronică, celule b - antineoplastic agents, protein kinase inhibitors, - calquence as monotherapy or in combination with obinutuzumab is indicated for the treatment of adult patients with previously untreated chronic lymphocytic leukaemia (cll). calquence as monotherapy is indicated for the treatment of adult patients with chronic lymphocytic leukaemia (cll) who have received at least one prior therapy.

European Union - Romanian - EMA (European Medicines Agency)

astrazeneca ab - selumetinib sulfate - neurofibromatosis 1 - agenți antineoplazici - koselugo as monotherapy is indicated for the treatment of symptomatic, inoperable plexiform neurofibromas (pn) in paediatric patients with neurofibromatosis type 1 (nf1) aged 3 years and above.

European Union - Romanian - EMA (European Medicines Agency)

astrazeneca ab - tixagevimab, cilgavimab - covid-19 virus infection - prevention of covid-19.

Romania - Romanian - ANMDM (Agentia Nationala a Medicamentului si a Dispozitivelor Medicale)

astrazeneca ab - suedia - esomeprazolum - compr. gastrorez. - 20mg - med. pt. trat. ulcerului gastro-duodenal si bolii-reflux g.e inhibitori ai pompei de protoni

Romania - Romanian - ANMDM (Agentia Nationala a Medicamentului si a Dispozitivelor Medicale)

astrazeneca ab - suedia - esomeprazolum - compr. gastrorez. - 40mg - med. pt. trat. ulcerului gastro-duodenal si bolii-reflux g.e inhibitori ai pompei de protoni

European Union - Romanian - EMA (European Medicines Agency)

astrazeneca ab - nirsevimab - seruri imune și imunoglobuline, - beyfortus is indicated for the prevention of respiratory syncytial virus (rsv) lower respiratory tract disease in neonates and infants during their first rsv season. beyfortus should be used in accordance with official recommendations.

Romania - Romanian - ANMDM (Agentia Nationala a Medicamentului si a Dispozitivelor Medicale)

astrazeneca ab - suedia - ticagrelor - compr. film. - 60 mg - antitrombotice antiagregante plachetare

Romania - Romanian - ANMDM (Agentia Nationala a Medicamentului si a Dispozitivelor Medicale)

astrazeneca ab - suedia - ticagrelor - compr. film. - 90 mg - antitrombotice antiagregante plachetare